Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76


RMP promotes venous metastases of hepatocellular carcinoma through promoting IL-6 transcription.

Zhang J, Pan YF, Ding ZW, Yang GZ, Tan YX, Yang C, Jiang TY, Liu LJ, Zhang B, Han T, Cao D, Yang T, Yang N, Wu MC, Dong LW, Wang HY.

Oncogene. 2015 Mar 19;34(12):1575-83. doi: 10.1038/onc.2014.84. Epub 2014 Apr 7.


14-3-3ζ promotes hepatocellular carcinoma venous metastasis by modulating hypoxia-inducible factor-1α.

Tang Y, Liu S, Li N, Guo W, Shi J, Yu H, Zhang L, Wang K, Liu S, Cheng S.

Oncotarget. 2016 Mar 29;7(13):15854-67. doi: 10.18632/oncotarget.7493.


RPB5-mediating protein is required for the proliferation of hepatocellular carcinoma cells.

Yang H, Gu J, Zheng Q, Li M, Lian X, Miao J, Jiang J, Wei W.

J Biol Chem. 2011 Apr 1;286(13):11865-74. doi: 10.1074/jbc.M110.136929. Epub 2011 Feb 10.


Comparative transcriptome analysis reveals that the extracellular matrix receptor interaction contributes to the venous metastases of hepatocellular carcinoma.

Zhang H, Ye J, Weng X, Liu F, He L, Zhou D, Liu Y.

Cancer Genet. 2015 Oct;208(10):482-91. doi: 10.1016/j.cancergen.2015.06.002. Epub 2015 Jun 18.


Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma.

Wang T, Hu HS, Feng YX, Shi J, Li N, Guo WX, Xue J, Xie D, Liu SR, Wu MC, Cheng SQ.

Br J Cancer. 2010 May 25;102(11):1618-26. doi: 10.1038/sj.bjc.6605689. Epub 2010 May 11.


OV6⁺ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma.

Yang W, Wang C, Lin Y, Liu Q, Yu LX, Tang L, Yan HX, Fu J, Chen Y, Zhang HL, Tang L, Zheng LY, He YQ, Li YQ, Wu FQ, Zou SS, Li Z, Wu MC, Feng GS, Wang HY.

J Hepatol. 2012 Sep;57(3):613-20. doi: 10.1016/j.jhep.2012.04.024. Epub 2012 May 19.


ICAM-1-Related Noncoding RNA in Cancer Stem Cells Maintains ICAM-1 Expression in Hepatocellular Carcinoma.

Guo W, Liu S, Cheng Y, Lu L, Shi J, Xu G, Li N, Cheng K, Wu M, Cheng S, Liu S.

Clin Cancer Res. 2016 Apr 15;22(8):2041-50. doi: 10.1158/1078-0432.CCR-14-3106. Epub 2015 Dec 14.


[Increased level of Th17 cells in peripheral blood correlates with the development of hepatocellular carcinoma].

Wang WW, Wang ZM, Liu YY, Qin YH, Shen Q.

Zhonghua Zhong Liu Za Zhi. 2010 Oct;32(10):757-61. Chinese.


Expression of the chemokine receptor CXCR4 in human hepatocellular carcinoma and its role in portal vein tumor thrombus.

Li N, Guo W, Shi J, Xue J, Hu H, Xie D, Wu M, Cheng S.

J Exp Clin Cancer Res. 2010 Nov 27;29:156. doi: 10.1186/1756-9966-29-156.


Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process.

Yau WL, Lam CS, Ng L, Chow AK, Chan ST, Chan JY, Wo JY, Ng KT, Man K, Poon RT, Pang RW.

PLoS One. 2013;8(3):e57882. doi: 10.1371/journal.pone.0057882. Epub 2013 Mar 6.


p28(GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis.

Qian YW, Chen Y, Yang W, Fu J, Cao J, Ren YB, Zhu JJ, Su B, Luo T, Zhao XF, Dai RY, Li JJ, Sun W, Wu MC, Feng GS, Wang HY.

Gastroenterology. 2012 Jun;142(7):1547-58.e14. doi: 10.1053/j.gastro.2012.02.042. Epub 2012 Feb 28.


Identification of two portal vein tumor thrombosis associated proteins in hepatocellular carcinoma: protein disulfide-isomerase A6 and apolipoprotein A-I.

Xu X, Wei X, Ling Q, Cheng J, Zhou B, Xie H, Zhou L, Zheng S.

J Gastroenterol Hepatol. 2011 Dec;26(12):1787-94. doi: 10.1111/j.1440-1746.2011.06796.x.


MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma.

Wang W, Lin H, Zhou L, Zhu Q, Gao S, Xie H, Liu Z, Xu Z, Wei J, Huang X, Zheng S.

Eur J Surg Oncol. 2014 Nov;40(11):1586-94. doi: 10.1016/j.ejso.2013.11.008. Epub 2013 Nov 19.


Aberrant estrogen receptor alpha expression correlates with hepatocellular carcinoma metastasis and its mechanisms.

Sheng ML, Xu GL, Zhang CH, Jia WD, Ren WH, Liu WB, Zhou T, Wang YC, Lu ZL, Liu WF, Dong XZ, Wang XJ, Lv Y.

Hepatogastroenterology. 2014 Jan-Feb;61(129):146-50.


DLK1 as a potential target against cancer stem/progenitor cells of hepatocellular carcinoma.

Xu X, Liu RF, Zhang X, Huang LY, Chen F, Fei QL, Han ZG.

Mol Cancer Ther. 2012 Mar;11(3):629-38. doi: 10.1158/1535-7163.MCT-11-0531. Epub 2012 Jan 11.


Foxp3+ regulatory T cells and the formation of portal vein tumour thrombus in patients with hepatocellular carcinoma.

Shen SL, Liang LJ, Peng BG, He Q, Kuang M, Lai JM.

Can J Surg. 2011 Apr;54(2):89-94. doi: 10.1503/cjs.028009.


Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis.

Wang C, Jiang K, Kang X, Gao D, Sun C, Li Y, Sun L, Zhang S, Liu X, Wu W, Yang P, Guo K, Liu Y.

Int J Biochem Cell Biol. 2012 Dec;44(12):2308-20. doi: 10.1016/j.biocel.2012.09.012. Epub 2012 Sep 23.


Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus.

Zhou J, Tang ZY, Fan J, Wu ZQ, Li XM, Liu YK, Liu F, Sun HC, Ye SL.

J Cancer Res Clin Oncol. 2000 Jan;126(1):57-61.


Cyclin G1 expands liver tumor-initiating cells by Sox2 induction via Akt/mTOR signaling.

Wen W, Han T, Chen C, Huang L, Sun W, Wang X, Chen SZ, Xiang DM, Tang L, Cao D, Feng GS, Wu MC, Ding J, Wang HY.

Mol Cancer Ther. 2013 Sep;12(9):1796-804. doi: 10.1158/1535-7163.MCT-13-0099. Epub 2013 Jun 26.

Supplemental Content

Support Center